These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 11053913)
21. Clinical and instrumental evaluation of the efficacy of a new depigmenting agent containing a combination of a retinoid, a phenolic agent and an antioxidant for the treatment of solar lentigines. Cameli N; Abril E; Agozzino M; Mariano M Dermatology; 2015; 230(4):360-6. PubMed ID: 25871836 [TBL] [Abstract][Full Text] [Related]
22. Sudden eruption of pigmentary spots on vitiligo universalis patient: possible misdiagnosis. Han EC; Lee KY; Shin JU; Park YK; Roh MR Acta Derm Venereol; 2009; 89(2):192-3. PubMed ID: 19326013 [No Abstract] [Full Text] [Related]
23. Inhibitors of intracellular signaling pathways that lead to stimulated epidermal pigmentation: perspective of anti-pigmenting agents. Imokawa G; Ishida K Int J Mol Sci; 2014 May; 15(5):8293-315. PubMed ID: 24823877 [TBL] [Abstract][Full Text] [Related]
24. Linear and whorled hypermelanosis. Di Lernia V Pediatr Dermatol; 2007; 24(3):205-10. PubMed ID: 17542865 [TBL] [Abstract][Full Text] [Related]
25. Combination of In-Office Chemical Peels With a Topical Comprehensive Pigmentation Control Product in Skin of Color Subjects With Facial Hyperpigmentation. Downie J; Schneider K; Goberdhan L; Makino ET; Mehta RC J Drugs Dermatol; 2017 Apr; 16(4):301-306. PubMed ID: 28403262 [TBL] [Abstract][Full Text] [Related]
27. Depigmenting action of a nanoemulsion containing heartwood extract of Artocarpus incisus on UVB-induced hyperpigmentation in C57BL/6 mice. Buranajaree S; Donsing P; Jeenapongsa R; Viyoch J J Cosmet Sci; 2011; 62(1):1-14. PubMed ID: 21443841 [TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo studies disclosed the depigmenting effects of gallic acid: a novel skin lightening agent for hyperpigmentary skin diseases. Kumar KJ; Vani MG; Wang SY; Liao JW; Hsu LS; Yang HL; Hseu YC Biofactors; 2013; 39(3):259-70. PubMed ID: 23322673 [TBL] [Abstract][Full Text] [Related]
29. 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation. Kolbe L; Mann T; Gerwat W; Batzer J; Ahlheit S; Scherner C; Wenck H; Stäb F J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():19-23. PubMed ID: 23205541 [TBL] [Abstract][Full Text] [Related]
30. Skin-lightening agents: new chemical and plant extracts--ongoing search for the Holy Grail! Kanthraj GR Indian J Dermatol Venereol Leprol; 2010; 76(1):3-6. PubMed ID: 20061723 [No Abstract] [Full Text] [Related]
32. Topical methimazole as a new treatment for postinflammatory hyperpigmentation: report of the first case. Kasraee B; Handjani F; Parhizgar A; Omrani GR; Fallahi MR; Amini M; Nikbakhsh M; Tran C; Hügin A; Sorg O; Saurat JH Dermatology; 2005; 211(4):360-2. PubMed ID: 16286748 [TBL] [Abstract][Full Text] [Related]
33. Postinflammatory hyperpigmentation: etiologic and therapeutic considerations. Callender VD; St Surin-Lord S; Davis EC; Maclin M Am J Clin Dermatol; 2011 Apr; 12(2):87-99. PubMed ID: 21348540 [TBL] [Abstract][Full Text] [Related]
34. Clinical efficacy and safety of 4-hexyl-1,3-phenylenediol for improving skin hyperpigmentation. Won YK; Loy CJ; Randhawa M; Southall MD Arch Dermatol Res; 2014 Jul; 306(5):455-65. PubMed ID: 24402285 [TBL] [Abstract][Full Text] [Related]
35. Histological effects of tazarotene 0.1% cream vs. vehicle on photodamaged skin: a 6-month, multicentre, double-blind, randomized, vehicle-controlled study in patients with photodamaged facial skin. Machtinger LA; Kaidbey K; Lim J; Loven KH; Rist TE; Wilson DC; Parizadeh DD; Sefton J; Holland JM; Walker PS Br J Dermatol; 2004 Dec; 151(6):1245-52. PubMed ID: 15606521 [TBL] [Abstract][Full Text] [Related]
36. Torilin from Torilis japonica inhibits melanin production in alpha-melanocyte stimulating hormone-activated B16 melanoma cells. Yun CY; Kim D; Lee WH; Park YM; Lee SH; Na M; Jahng Y; Hwang BY; Lee MK; Han SB; Kim Y Planta Med; 2009 Nov; 75(14):1505-8. PubMed ID: 19533579 [TBL] [Abstract][Full Text] [Related]
38. Potent low toxicity inhibition of human melanogenesis by novel indole-containing octapeptides. Ubeid AA; Do S; Nye C; Hantash BM Biochim Biophys Acta; 2012 Oct; 1820(10):1481-9. PubMed ID: 22609875 [TBL] [Abstract][Full Text] [Related]
39. Tolerance and efficacy of a product containing ellagic and salicylic acids in reducing hyperpigmentation and dark spots in comparison with 4% hydroquinone. Dahl A; Yatskayer M; Raab S; Oresajo C J Drugs Dermatol; 2013 Jan; 12(1):52-8. PubMed ID: 23377328 [TBL] [Abstract][Full Text] [Related]
40. Chemical analysis of constitutive pigmentation of human epidermis reveals constant eumelanin to pheomelanin ratio. Del Bino S; Ito S; Sok J; Nakanishi Y; Bastien P; Wakamatsu K; Bernerd F Pigment Cell Melanoma Res; 2015 Nov; 28(6):707-17. PubMed ID: 26285058 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]